Skip to main content

VT vs SVT Brugada Algorithm

 

VT vs SVT Brugada Algorithm
VT vs SVT With Aberrancy


Brugada Algorithm Explained



---


Introduction


Wide complex tachycardia (WCT) is defined as a tachycardia with QRS duration ≥120 ms. The two most common causes are:


• Ventricular Tachycardia (VT)

• Supraventricular Tachycardia with Aberrancy (SVT-A)


Distinguishing between them is critical because misdiagnosing VT as SVT can lead to inappropriate therapy and clinical deterioration.


The Brugada Algorithm, introduced by Brugada et al. (1991), is one of the most widely used ECG methods to differentiate VT from SVT with aberrant conduction.



---


Brugada Algorithm (Stepwise Approach)


The algorithm consists of 4 sequential ECG questions.

If the answer to any step is YES → Diagnose VT.


If NO → Move to the next step.



---


Step 1: Absence of RS Complex in All Precordial Leads


Look at V1–V6.


Check whether any lead has an RS complex.


RS complex = an R wave followed by an S wave.


If no RS complex is present in all precordial leads → VT


This means the QRS complexes are either:


• monophasic R

• monophasic QS

• entirely negative complexes


Why this suggests VT


In VT, ventricular activation does not use the normal His–Purkinje system, resulting in uniform depolarization patterns without RS morphology.



---


Step 2: RS Interval > 100 ms


If an RS complex is present, measure the RS interval.


RS interval =

Start of R wave → Lowest point of S wave


Measure in any precordial lead.


If RS interval >100 ms → VT


Reason


Delayed ventricular activation occurs when impulses travel cell-to-cell rather than through Purkinje fibers.



---


Step 3: AV Dissociation


Look for atrial and ventricular activity occurring independently.


Signs of AV dissociation include:


• P waves marching independently of QRS

• Capture beats

• Fusion beats

• Variable PR intervals


If AV dissociation is present → VT


Why this occurs


In VT, the ventricles drive the rhythm while the atria continue to depolarize independently via the sinus node.



---


Step 4: Morphologic Criteria for VT


If the first three steps are negative, analyze QRS morphology in V1/V2 and V6.


Morphology differs depending on RBBB-like or LBBB-like pattern.



---


VT Morphology with RBBB Pattern (V1)


Suggests VT if:


• Monophasic R wave in V1

• Broad R wave (>30 ms)

• RS interval prolonged

• Notch on descending limb of S wave


In Lead V6


• QS or rS complex favors VT



---


VT Morphology with LBBB Pattern (V1)


Suggests VT if:


• Initial R wave >30 ms

• Notching of downstroke of S wave

• Prolonged onset to nadir of S wave (>60 ms)


In Lead V6


• QS or rS complex favors VT



---


Sensitivity and Accuracy


Original Brugada study reported:


• Sensitivity for VT ≈ 98%

• Specificity ≈ 96%


However, real-world accuracy may be slightly lower, especially in:


• Pre-existing bundle branch block

• Antiarrhythmic drug use

• Fascicular VT



---


Practical Clinical Rule


A widely taught emergency rule:


If a wide complex tachycardia is seen in an adult → Assume VT until proven otherwise.


Reasons:


• VT accounts for ~80% of WCT

• Risk of deterioration with wrong therapy



---


Limitations of Brugada Algorithm


Despite its usefulness, several limitations exist:


• Requires careful ECG interpretation

• Difficult during very rapid tachycardia

• Less reliable with preexisting BBB

• May fail in fascicular VT or antidromic AVRT


Because of these limitations, other algorithms were developed:


• Vereckei Algorithm

• aVR Algorithm

• Griffith Algorithm



---


Key ECG Features Favoring VT (Quick Summary)


Strong indicators of VT include:


• AV dissociation

• Capture beats

• Fusion beats

• Extreme axis deviation

• Concordance in precordial leads

• Very broad QRS (>160 ms)



---


Clinical Importance


Correct differentiation between VT and SVT with aberrancy is essential because treatment strategies differ:


VT Management


• Amiodarone

• Procainamide

• Electrical cardioversion

• ICD therapy in structural heart disease


SVT with Aberrancy


• Adenosine

• AV nodal blockers

• Vagal maneuvers


Administering AV nodal blockers in VT can cause hemodynamic collapse.



---


Take-Home Message


The Brugada Algorithm remains one of the most practical ECG tools for differentiating VT from SVT with aberrancy.


The key concept is simple:


1. No RS complex → VT



2. RS interval >100 ms → VT



3. AV dissociation → VT



4. VT morphology → VT




If none of these criteria are present, the rhythm is more likely SVT with aberrancy.


However, in clinical practice, treat any uncertain wide complex tachycardia as VT to avoid dangerous mismanagement.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...